Therapeutic effect of statin on aortic stenosis: A review with meta-analysis

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 4, 2010, Pages 385-393

  Ge, H ^a   Zhang, Q ^a   Wang, B Y ^a   He, B ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; EZETIMIBE PLUS SIMVASTATIN; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AORTA VALVE STENOSIS; CALCIFICATION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE COURSE; HEMODYNAMIC PARAMETERS; HUMAN; HYPERTENSION; PRESSURE GRADIENT; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

AORTIC VALVE STENOSIS; DISEASE PROGRESSION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;

EID: 77954491583     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01137.x     Document Type: Review

References (33)

1. Stewart BF, Siscovick D, Lind BK et al. (1997) Clinical factors associated with calcific aortic valve disease. Journal of the American College of Cardiology, 29, 630 634.
2. Lindroos M, Kupari M, Heikkilä J et al. (1993) Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. Journal of the American College of Cardiology, 21, 1220 1225.
3. Otto CM, Burwash IG, Legget ME et al. (1997) Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation, 95, 2262 2270.
4. Iivanainen AM, Lindroos M, Tilvis R et al. (1996) Calcific degeneration of the aortic valve in old age: is the development of flow obstruction predictable? Journal of Internal Medicine, 239, 269 273.
5. O'Brien KD, Reichenbach DD, Marcovina SM et al. (1996) Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 16, 523 532.
6. Olsson M, Thyberg J, Nilsson J (1999) Presence of oxidized low-density lipoprotein in nonrheumatic stenotic aortic valves. Arteriosclerosis, Thrombosis, and Vascular Biology, 19, 1218 1222.
7. Otto CM, Kuusisto J, Reichenbach DD et al. (1994) Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation, 90, 844 853.
8. Deutscher S, Rockette HE, Krishnaswami V (1984) Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. Journal of Chronic Diseases, 37, 407 415.
9. Mohler ER, Sheridan MJ, Nichols R et al. (1991) Development and progression of aortic valve stenosis: atherosclerosis risk factors - a causal relationship? A clinical morphologic study. Clinical Cardiology, 14, 995 999.
10. Aronow WS, Ahn C, Kronzon I et al. (2001) Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. American Journal of Cardiology, 88, 693 695. (Pubitemid 32831111)
11. Novaro GM, Tiong IY, Pearce GL et al. (2001) Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation, 104, 2205 2209.
12. Bellamy MF, Pellikka PA, Klarich KW et al. (2002) Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. Journal of the American College of Cardiology, 40, 1723 1730.
13. Shavelle DM, Takasu J, Budoff MJ et al. (2002) HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet, 359, 1125 1126.
14. Rosenhek R, Rader F, Loho N et al. (2004) Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation, 110, 1291 1295.
15. Cowell SJ, Newby DE, Prescott RJ et al. (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. New England Journal of Medicine, 352, 2389 2397.
16. Moura LM, Ramos SF, Zamorano JL et al. (2007) Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. Journal of the American College of Cardiology, 49, 554561.
17. Rossebø AB, Pedersen TR, Boman K et al. (2008) Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. New England Journal of Medicine, 359, 1343 1356.
18. Emile R, Mohler ER III., Wang H et al. (2007) Effect of statin treatment on aortic valve and coronary artery calcification. Journal of Heart Valve Disease, 16, 378 386.
19. Mehrabi MR, Sinzinger H, Ekmekcioglu C et al. (2000) Accumulation of oxidized LDL in human semilunar valves correlates with coronary atherosclerosis. Cardiovascular Research, 45, 874 882.
20. Ghaisas NK, Foley JB, O'Briain DS et al. (2000) Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement. Journal of the American College of Cardiology, 36, 2257 2262.
21. Edep ME, Shirani J, Wolf P et al. (2000) Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovascular Pathology, 9, 281 286.
22. Kaden JJ, Dempfle CE, Grobholz R et al. (2005) Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovascular Pathology, 14, 80 87.
23. Rallidis L, Naoumova RP, Thompson GR et al. (1998 Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia. Heart, 80, 583 590.
24. Galante A, Pietroiusti A, Vellini M et al. (2001) C-reactive protein is increased in patients with degenerative aortic valvular stenosis. Journal of the American College of Cardiology, 38, 1078 1082.
25. Rajamannan NM, Subramaniam M, Springett M et al. (2002) Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation, 105, 2660 2665.
26. Rajamannan NM, Subramaniam M, Caira F et al. (2005) Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation, 112, I229 I234.
27. Otto CM, Pearlman AS, Gardner CL et al. (1989) Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. Journal of the American College of Cardiology, 13, 545 550.
28. Faggiano P, Ghizzoni G, Sorgato A et al. (1992) Rate of progression of valvular aortic stenosis in adults. American Journal of Cardiology, 70, 229 233.
29. Roger VL, Tajik AJ, Bailey KR et al. (1990) Progression of aortic stenosis in adults: new appraisal using Doppler echocardiography. American Heart Journal, 119, 331 338.
30. Rosenhek R, Klaar U, Schemper M et al. (2004) Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. European Heart Journal, 25, 199 205.
31. Aronow WS, Ahn C, Shirani J et al. (1998) Comparison of frequency of new coronary events in older persons with mild, moderate, and severe valvular aortic stenosis with those without aortic stenosis. American Journal of Cardiology, 81, 647 649.
32. Otto CM, Lind BK, Kitzman DW et al. (1999) Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. New England Journal of Medicine, 341, 142 147.
33. Antonini-Canterin F, Hirsu M, Popescu BA et al. (2008) Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis. American Journal of Cardiology, 102, 738 742.